Combining the results of the GO and KEGG enrichment analyses with the results of the in vivo experiments indicates that FZP exerts its antitumor effect through PD‐L1 expression and the PD‐1 checkpoint pathway in cancer, as well as the biological process of negative regulation of cell death or programmed cell death. The gene discussed is CD274; the disease is cancer.